Furthermore, it has been reported that, after binding with its ligands, FGFR could activate its downstream pathway, such as PI3K/Akt, p38 and smad2/3, and consequently impel the proliferation and invasion of tumor cells [19]. Here, SMAD2 is linked to neoplasm.